The abstract is read at the publisher; the summary is JClub's.
An updated monoclonal antibody panel was built using 11 human neutralizing antibodies from VelocImmune mice immunized with KP.3.1.1 spike to track SARS-CoV-2 JN.1 subvariant antigenic evolution.
- Why it matters: Existing mAbs often lose activity against newer variants, making it hard to map how emerging mutations change antibody neutralization and antigenic properties.
- What they did: Naive, unimprinted VelocImmune mice were immunized with KP.3.1.1 spike, yielding 11 human neutralizing antibodies across diverse epitopes, which were combined with characterized mAbs into a profiling toolbox.
- The result: Using this panel on emerging variants showed mechanistic signals for recent antigenic evolution, including altered receptor-binding domain conformation, and distinct antibody-evasion profiles between JN.1-derived and BA.3.2 lineages.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.